Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya

Clinical trial NCT02137707 · COMPLETED

Trial details

NCT number: NCT02137707
Sponsor: McGill University
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis-Relapsing-Remitting

Start date: 2012-11-01
Primary completion: 2017-11-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.